Documents | Eleven therapeutics oligonucleotide customer case.

Eleven therapeutics oligonucleotide customer case.

In 2021, Biotage acquired ATDBio, a world leader in custom oligonucleotides. Gene therapy startup Eleven Therapeutics have a close collaboration with ATDBio. We sat down with their CEO Prof. Yaniv Erlich to learn more. This customer case discusses how Eleven therapeutics have utilized Biotage oligonucleotides to drive their business forward.

Download Options

Download

E-mail a Copy

About Biotage

Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).

Ask a specialist

Eleven therapeutics oligonucleotide customer case.